4503 On Other Exchanges
Symbol
Exchange
4503 is not on other exchanges.

Executive Profile*

Sef P. Kurstjens M.D., Ph.D.

Chief Medical Officer and President of Global Development,Astellas Pharma Inc.
AgeTotal Calculated CompensationThis person is connected to 61 board members in 1 different organizations across 3 different industries.

See Board Relationships
----

Background*

Dr. Sef P. Kurstjens, M.D., Ph.D. serves as Chief Medical Officer at Astellas Pharma Inc. Dr. Kurstjens has been the President of Astellas Pharma Global Development, Inc. since October 2013. Dr. Kurstjens serves as Chief Medical Officer of Astellas Pharma, Inc. Dr. Kurstjens served as the President and the Chief Executive Officer at Agensys, Inc. since November 2010. Dr. Kurstjens served as the Senior Vice President, Chief Medical Officer and Head, Global Drug Development ...

Read Full Background

Corporate Headquarters*

2-5-1, Nihonbashi-Honcho
Tokyo, -- 103-8411

Japan

Phone: 81 3 3244 3000
Fax: --

Board Members Memberships*

2011-Present
Director

Education*

Unknown/Other Education
Wits Medical School

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Vincent A. Forlenza Chairman, Chief Executive Officer and President
Becton, Dickinson and Company
$1.1M
José E. Almeida Chairman and Chief Executive Officer
Baxter International Inc.
$231.5K
Joseph C. Papa Chairman of the Board and Chief Executive Officer
Valeant Pharmaceuticals International, Inc.
--
Jean-Pierre Clamadieu Chief Executive Officer, Director and Member of Finance Committee
Solvay SA
--
Christophe Weber Chief Executive Officer, President and Representative Director
Takeda Pharmaceutical Company Limited
¥495.0M
Compensation as of Fiscal Year 2016.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact ASTELLAS PHARMA INC, please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.